Endocyte Inc. (ECYT)

9.03
NASDAQ : Health Technology
Prev Close 9.03
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.17 / 11.54
Avg Volume 2.33M
Exchange NASDAQ
Shares Outstanding 68.74M
Market Cap 617.28M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?

First Week of ECYT October 19th Options Trading

First Week of ECYT October 19th Options Trading

Investors in Endocyte Inc saw new options begin trading this week, for the October 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Focused on Stock Picking Through This Volatility

Focused on Stock Picking Through This Volatility

I'm trying not to be sucked into the market-timing game and am looking mainly at setups in individual stocks.

Closing Bell; Endocyte Spikes: LIVE MARKETS BLOG

Closing Bell; Endocyte Spikes: LIVE MARKETS BLOG

A drug licensing agreement sent Endocyte skyrocketing.

Endocyte Reports First Quarter Financial Results And Provides Clinical And Pipeline Update

- Conference Call Today at 8:30 a.m. EDT -

TheStreet Quant Rating: D (Sell)